About F2G
F2G develops novel therapeutics for rare, life-threatening fungal infections. The company creates new antifungal drugs, including olorofim, which is part of a new class of antifungal drugs called orotomides. F2G aims to provide more treatment options for patients fighting these infections.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Manchester, United Kingdom
Team Size
51-100
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
f2g.com
Domain Registered Date
Nov 22, 1999
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $100,000,000 · Series-B+
fundraisingfox.com
- Milestone
Website domain registered
f2g.com
Investors & Backers
Advent Life Sciences
AMR Action Fund
Brace Pharma
Cowen Healthcare Investments
European Investment Bank Group
Forbion Capital Partners
Intermediate Capital Group
Morningside
Novo Ventures
Sofinnova Partners
Funding History
Series-B+
· Sep 12, 2024
$100,000,000 fundraisingfox.com
Founders & Leadership
Christopher Wright
Non Executive Director
Work email & phone locked
Unlock →
David Denning
Founder
Work email & phone locked
Unlock →
Ian Nicholson
Chief Executive Officer
Work email & phone locked
Unlock →
Janelle Anderson
Chief Business Officer
Work email & phone locked
Unlock →
John Rex
Chief Medical Officer
Work email & phone locked
Unlock →
Mike Birch
Chief Operating Officer
Work email & phone locked
Unlock →
Raj Parekh
Non Executive Director
Work email & phone locked
Unlock →
Ralf Schmid
Chief Financial Officer
Work email & phone locked
Unlock →
Tony Kennedy
Chief Scientific and Development Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026